MedTrace Logo

A Registry Study of Patients Hospitalized With Confirmed COVID-19

NCT05792865 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2023-03-31

No results posted yet for this study

Summary

The design of this registered study aims to evaluate the efficacy and safety of Paxlovid in the treatment of hospitalized COVID-19 patients, and to explore factors related to the efficacy and safety of Paxlovid.

Conditions

Interventions

DRUG

paxlovid

Patients treated with PAXLOVID within 5 days of being diagnosed with covid-19 will be included in this group. Patients treated with PAXLOVID will be included in this group. This study is a non-interventional observational study, and no intervention measures were applied to the clinical diagnosis and treatment process of hospitalized COVID-19 patients. The use of Paxlovid is completely decided by the clinical doctors based on the patients' condition and clinical experience.

DRUG

No paxlovid

Patients not treated with PAXLOVID will be included in this group. This study is a non-interventional observational study, and no intervention measures were applied to the clinical diagnosis and treatment process of hospitalized COVID-19 patients. The use of Paxlovid is completely decided by the clinical doctors based on the patients' condition and clinical experience.

DRUG

Paxlovid

Patients treated with PAXLOVID outside of the initial 5 days after being diagnosed with covid-19 will be included in this group.

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Yi Zhang, PhD · Beijing Chao Yang Hospital

  • Zhuoling An, PhD · Beijing Chao Yang Hospital

  • Chaohui Tong, PhD · Beijing Chao Yang Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2023-06-30
Completion
2023-12-30
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05792865 on ClinicalTrials.gov